Hyperproteic Nutrition:Correlation of BUN to Nitrogen Balance

NCT ID: NCT00480259

Last Updated: 2018-06-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

8 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-06-01

Study Completion Date

2009-04-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to determine if the following are true. When protein requirements exceed metabolic requirements, blood urea nitrogen(BUN) levels will rise. Elevated BUN levels in the absence of renal failure, hepatic failure, or GI bleeding, will be correlated with improved nitrogen balance and inversely correlated with infection rates, days of mechanical ventilation, ICU days, and total hospital days.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is threefold. First, to determine if a correlation exists between BUN and nitrogen balance in the context of hyperproteic nutrition administration. Creatinine clearance will also be followed to determine if there is any harmful effect to the kidney secondary to an elevated BUN. Secondly, to determine if there is a difference in hospital acquired infection rate, ventilator days, ICU days, and hospital stay between the current nutrition standard at Penn State Hershey Medical Center and a hyperproteic nutrition protocol. Thirdly, to determine the accuracy of at least three calculated creatinine clearance formulae when compared to a measured creatinine clearance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Enteral Feeding

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Nutrition

Group Type ACTIVE_COMPARATOR

hyperproteic nutrition

Intervention Type BEHAVIORAL

Hyperprotein Nutrition

Group Type EXPERIMENTAL

hyperproteic nutrition

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hyperproteic nutrition

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Greater then or equal to 18 years of age and patient in Intensive Care Unit
* Receiving enteral nutrition, with expected duration of at least 5 days
* Blood urea nitrogen and creatinine clearance are part of routine blood work
* Indwelling urinary catheter in place

Exclusion Criteria

* Renal or hepatic failure
* Current or history(past 6 mos) of GI bleeding
* Serum creatinine on day of screening of equal to or greater then 1.5 mg/dl
* Creatinine Clearance on day of screening of equal to or less then 30ml/min
* Hypovolemia resulting in increased BUN
* Septic shock
* Blood urea nitrogen on day of screening equal to or greater then 30mg/dl
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Milton S. Hershey Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John K Stene, MD

Role: PRINCIPAL_INVESTIGATOR

Penn State University, College of Medicine, Dept of Anesthesiology

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

25351

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Basel Enteral High Protein Study
NCT02678325 TERMINATED NA
Indicator Amino Acid Oxidation in ICU Patients
NCT06104527 ACTIVE_NOT_RECRUITING NA
Amino Acid Nutrition in the Critically-ill
NCT02865408 ACTIVE_NOT_RECRUITING NA
Protein Requirements in Endurance-trained Athlete
NCT02478801 COMPLETED EARLY_PHASE1